The Current and Future Status of Biomarkers in Osteoarthritis

REFERENCES

1. 1.↵
   1. Aslam I,
   2. Perjar I,
   3. Shi X,
   4. Renner J,
   5. Kraus V,
   6. Golightly Y,
   7. et al.

   Associations between biomarkers of joint metabolism, hand osteoarthritis, and hand pain and function: The Johnston County Osteoarthritis Project. J Rheumatol 2014;41:938–44.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Kraus VB

   . Do biochemical markers have a role in osteoarthritis diagnosis and treatment? Best Pract Res Clin Rheumatol 2006;20:69–80.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Hoch JM,
   2. Mattacola CG,
   3. Medina McKeon JM,
   4. Howard JS,
   5. Lattermann C

   . Serum cartilage oligomeric matrix protein (sCOMP) is elevated in patients with knee osteoarthritis: a systematic review and meta-analysis. Osteoarthritis Cart 2011;19:1396–404.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. van Spil WE,
   2. DeGroot J,
   3. Lems WF,
   4. Oostveen JC,
   5. Lafeber FP

   . Serum and urinary biochemical markers for knee and hip-osteoarthritis: a systematic review applying the consensus BIPED criteria. Osteoarthritis Cart 2010;18:605–12.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Bauer DC,
   2. Hunter DJ,
   3. Abramson SB,
   4. Attur M,
   5. Corr M,
   6. Felson D,
   7. et al.

   Classification of osteoarthritis biomarkers: a proposed approach. Osteoarthritis Cart 2006;14:723–7.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Cibere J,
   2. Zhang H,
   3. Thorne A,
   4. Wong H,
   5. Singer J,
   6. Kopec JA,
   7. et al.

   Association of clinical findings with pre-radiographic and radiographic knee osteoarthritis in a population-based study. Arthritis Care Res (Hoboken) 2010;62:1691–8.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Criscione LG,
   2. Elliott AL,
   3. Stabler T,
   4. Jordan JM,
   5. Pieper CF,
   6. Kraus VB

   . Variation of serum hyaluronan with activity in individuals with knee osteoarthritis. Osteoarthritis Cart 2005;13:837–40.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Addison S,
   2. Coleman RE,
   3. Feng S,
   4. McDaniel G,
   5. Kraus VB

   . Whole-body bone scintigraphy provides a measure of the total-body burden of osteoarthritis for the purpose of systemic biomarker validation. Arthritis Rheum 2009;60:3366–73.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Prostate-specific antigen (PSA) test

   . National Cancer Institute 2012. [Internet. Accessed March 6, 2014.] Available from: www.cancer.gov/cancertopics/factsheet/detection/PSA
10. 10.↵
    1. Schmidt C

    . CA-125: a biomarker put to the test. J Natl Cancer Inst 2011;103:1290–1.

    OpenUrlFREE Full Text
11. 11.↵
    1. Duffy MJ,
    2. van DA,
    3. Haglund C,
    4. Hansson L,
    5. Klapdor R,
    6. Lamerz R,
    7. et al.

    Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines. Eur J Cancer 2003;39:718–27.

    OpenUrlCrossRefPubMed